Oppenheimer Upgrades Sarepta Therapeutics (SRPT) to Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. DGNX
4. RDDT
5. BRUN
6. ELUT
7. BBIO
8. SMSI
9. SNDK
10. ADYEN:NA

May 14, 2024 6:10 AM EDT
Get Alerts SRPT Hot Sheet
Price: $18.42 --0%

Rating Summary:
    19 Buy, 18 Hold, 6 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 12 | New: 8
Join SI Premium – FREE

Oppenheimer analyst Hartaj Singh upgraded Sarepta Therapeutics (NASDAQ: SRPT) from Perform to Outperform with a price target of $180.00.


For an analyst ratings summary and ratings history on Sarepta Therapeutics click here. For more ratings news on Sarepta Therapeutics click here.


Shares of Sarepta Therapeutics closed at $131.70 yesterday.


You May Also Be Interested In





Related Categories

Upgrades